Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prostaflog
- Development stage
- Unknown
- Lead developer
- Naturneed
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Prostaflog is a dietary supplement formulated with a combination of plant extracts, including turmeric (Curcuma longa), Boswellia (Boswellia serrata), nettle (Urtica dioica), maritime pine (Pinus pinaster), and soy lecithin (Glycine max). Developed by Naturneed, it is designed to support prostate health and urinary tract function. Clinical studies have evaluated its efficacy in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and elevated prostate-specific antigen (PSA) levels, demonstrating its ability to reduce inflammation, lower pro-inflammatory cytokine levels (such as IL-8), and decrease seminal vesicle volume.
- Brand names
- Prostaflog
Beyond the preview
Go deeper on Prostaflog.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prostaflog.